跳到主要内容
知仓学习社ZHICANG

jama-pediatrics

Use when targeting JAMA Pediatrics or deciding whether a child- or adolescent-health study fits this venue. Encodes the journal's fit, the pediatric…

不碰外部(只输出文字)无严重或高危命中brycewang-stanford/Awesome-Journal-Skills

它会碰到什么

扫了多少1 个文本文件,7 KB
它会碰到什么不碰外部(只输出文字)
命中总数0 处
命中统计严重 0 · 高 0 · 中 0 · 低 0

这一栏是扫描器报的事实,不是结论。命中多不等于有毒(安全工具、规则库、示例脚本本来就会包含危险写法),命中少也不等于干净。它和你手上的凭据、文件、网络有什么关系,需要你自己看。

技能内容

JAMA Pediatrics (jama-pediatrics)

Journal positioning

JAMA Pediatrics is a JAMA Network specialty journal for clinical and population

research on the health of infants, children, and adolescents. It favors rigorous,

practice- and policy-relevant work — randomized pediatric trials, large child-health

cohorts and population studies, prevention and developmental research, and health-

services analyses — with JAMA's emphasis on age-appropriate outcomes, adequate power,

and direct relevance to child and adolescent care. Studies that simply extrapolate

adult findings, small descriptive series, and work using adult-derived outcomes

without pediatric validation are a weak fit. This skill is a **fit / venue-selection /

re-framing** aid; it is not clinical or regulatory advice and does not replace the

journal's current instructions for authors. Before submitting, re-check the live JAMA

Pediatrics author instructions.

When to trigger

  • The author names JAMA Pediatrics for a child- or adolescent-health clinical,

developmental, or population study and wants a fit/framing check.

  • A pediatric study must be re-framed around an age-appropriate, developmentally valid

outcome for a child-health readership.

  • The author is choosing between JAMA Pediatrics, JAMA, and a pediatric-subspecialty

journal.

  • The author needs the journal's pediatric-specific design, ethics (assent/parental

consent), reporting-guideline, registration, and desk-reject expectations.

Scope & topic fit

  • Randomized pediatric trials (therapeutic, behavioral, preventive, or vaccine) with

age-appropriate primary outcomes, including pragmatic designs.

  • Large child- and adolescent-health cohorts, birth cohorts, and population/registry

studies with rigorous confounding control.

  • Developmental, neurodevelopmental, growth, nutrition, and early-life-exposure studies

with validated pediatric measures.

  • Adolescent health, mental-health, injury-prevention, and child-maltreatment research

with appropriate sensitivity and ethics.

  • Pediatric health-services, quality, vaccine-policy, and disparities research.
  • Systematic reviews and meta-analyses answering a focused child-health question.

Method & evidence bar

  • Trials and studies must use age- and developmentally appropriate, validated outcome

measures and be adequately powered; adult-derived endpoints need pediatric validation.

  • The applicable reporting guideline and checklist are required: CONSORT for trials,

STROBE for observational studies, PRISMA for systematic reviews; report stratification

by age/developmental stage where relevant.

  • Trials require prospective registration; registration number, protocol, and

statistical-analysis plan are expected.

  • Pediatric ethics must be explicit: IRB approval, parental/guardian permission, child

assent appropriate to age, and protections for vulnerable populations (neonates,

adolescents, maltreatment).

  • Observational and exposure claims must address confounding, family clustering, and

missing data; causal language must match the design.

  • Long-term developmental outcomes need adequate follow-up and handling of attrition.

Structure & house style

  • JAMA Network format with a structured abstract and a Key Points box; re-check current

article types (Original Investigation, Brief Report, Research Letter, etc.) and limits

on the live guide.

  • The introduction frames a focused, child-health-relevant question; the discussion

states the clinical, developmental, or policy implication plainly.

  • Tables/figures follow JAMA Network statistical-reporting standards; CONSORT/STROBE

flow diagrams and age-stratified results are expected where applicable.

  • Supplements carry the protocol, SAP, consent/assent documentation summary, and

additional analyses.

Official-submission checklist

  • Before giving submission-ready advice, read ../../resources/source-basis.md and

../../resources/official-source-map.md; start from the ICMJE and JAMA Network

anchors, then cite the current JAMA Pediatrics page you checked.

  • Search the live site for "JAMA Pediatrics instructions for authors" and follow the

current version.

  • Re-check article types and word/reference/table limits, structured-abstract and Key

Points format, and the JAMA Network statistical-reporting requirements.

  • Confirm trial registration, the reporting checklist (CONSORT/STROBE/PRISMA), the

data-sharing statement, and protocol/SAP submission.

  • Re-check IRB/ethics, parental consent and child assent, vulnerable-population

protections, ICMJE disclosures, funding, and AI-use disclosure.

  • If the live official instructions conflict with this skill, the official instructions

win.

Pre-submission self-check

  • [ ] The study answers a child-/adolescent-health question with age-appropriate, validated outcomes.
  • [ ] The primary outcome is prespecified and developmentally valid; the study is adequately powered, stratified by age where relevant.
  • [ ] The correct reporting checklist (CONSORT/STROBE/PRISMA) is completed and attached.
  • [ ] Trials are prospectively registered with the number in the manuscript; protocol/SAP provided.
  • [ ] Pediatric ethics are explicit: IRB, parental consent, child assent, and vulnerable-population protections.
  • [ ] ICMJE disclosures and a data-sharing statement are prepared; confounding and attrition are addressed.

Common desk-reject triggers

  • Adult findings extrapolated to children, or adult-derived outcomes used without pediatric validation.
  • Small descriptive pediatric series with no clear practice, developmental, or policy implication.
  • Missing or inadequate assent/parental-consent and vulnerable-population protections.
  • Observational analyses with unaddressed confounding/family clustering or overstated causal claims.
  • Missing trial registration, protocol, or the required reporting checklist.
  • Narrow pediatric-subspecialty interest better served by a subspecialty journal.

Re-routing decision

  • Broadly practice-changing, top-tier pediatric trial → general medicine (jama / NEJM / The Lancet in the natural-science bundle).
  • Adult internal-medicine relevance over pediatrics → jama-internal-medicine.
  • Child/adolescent mental-health primary focus → jama-psychiatry / the-lancet-psychiatry.
  • Pediatric neurological/developmental-neurology focus → jama-neurology / brain.
  • Pediatric surgical or perioperative focus → jama-surgery.

Output format

[Fit] High / Medium / Low (one-line reason)
[Target] JAMA Pediatrics
[Specialty tags] <2–3 closest child-/adolescent-health topics>
[Study design / reporting guideline] <RCT-CONSORT / cohort-STROBE / review-PRISMA>
[Method/evidence] <does power, age-appropriate outcome, registration, and pediatric ethics clear the bar?>
[Top risk] <the single most likely reason for rejection>
[Official items to re-check] <article type / registration / checklist / assent-consent / ethics / disclosures>
[Re-route suggestion] <if not a fit, a better-matched venue>

想直接用这个技能?

本站把开放许可(MIT / Apache 等)的技能按仓库打包整理到网盘,点一下转存到你自己的网盘,不用一个个从 GitHub 拉。许可未声明的技能只给原始仓库链接,不打包。